EN2 and posterior cortical atrophy: In particular, Morgan et al. demonstrated that patients with PCa had 10-fold increased urine EN2 levels compared to controls, showing a specificity of 88% to diagnose PCa [20], which suggested the putative utility of urine EN2 levels as a novel non-invasive PCa biomarker.